Gover Justin D.
Insider CIK 1754129 · GWPH Chief Executive Officer, Director · XENE Director · DSGN Director · CMPS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DSGN Design Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-06-03 | 2026-06-03 | 1,593 | — | $0 | 1,593 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2026-06-03 | 2026-06-03 | 10,507 | — | $0 | 10,507 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2026-06-01 | 2026-06-03 | 2,645 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2026-06-01 | 2026-06-03 | 2,645 | — | $0 | 2,645 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2026-05-27 | 2026-05-29 | 21,110 | — | $0 | 21,110 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2025-09-09 | 2025-09-10 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DSGN Design Therapeutics, Inc. | A Award deriv | 2025-09-09 | 2025-09-10 | 15,833 | — | $0 | 15,833 | SEC↗ |
| CMPS COMPASS Pathways plc | A Award deriv | 2025-07-29 | 2025-07-30 | 52,000 | — | $0 | 52,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 2,645 | — | $0 | 2,645 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 17,012 | — | $0 | 17,012 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2024-06-05 | 2024-06-05 | 15,542 | — | $0 | 15,542 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2023-08-10 | 2023-08-10 | 28,000 | — | $0 | 28,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 213,240 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 75,864 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 17,508 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 263,184 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 164,496 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 479,844 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 287,904 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 55,488 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 12,492 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 226,752 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 34,008 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 22,440 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 30,936 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 119,472 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 147,624 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 142,344 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2021-05-05 | 2021-05-07 | 1,867,308 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2021-05-05 | 2021-05-07 | 222,773 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2021-05-05 | 2021-05-07 | 456,048 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | G Gift | 2021-03-19 | 2021-03-22 | 276,000 | — | $0 | 1,867,308 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-03-02 | 2021-03-04 | 263,184 | — | $0 | 263,184 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-03-02 | 2021-03-04 | 164,496 | — | $0 | 164,496 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-03-01 | 2021-03-02 | 17,004 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-03-01 | 2021-03-02 | 8,412 | $17.85 | $150.2K | 222,773 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-03-01 | 2021-03-02 | 17,004 | — | $0 | 231,185 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-02-26 | 2021-03-02 | 24 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-02-26 | 2021-03-02 | 101,436 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-02-26 | 2021-03-02 | 299,196 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-02-26 | 2021-03-02 | 22,440 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-02-26 | 2021-03-02 | 11,086 | $17.90 | $198.4K | 11,359 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-02-26 | 2021-03-02 | 22,440 | — | $0 | 22,445 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-02-26 | 2021-03-02 | 49,992 | $17.90 | $894.9K | 214,181 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-02-26 | 2021-03-02 | 101,412 | — | $0 | 264,173 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-02-26 | 2021-03-02 | 12 | $17.90 | $215 | 162,761 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-02-26 | 2021-03-02 | 24 | — | $0 | 162,773 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-02-26 | 2021-03-02 | 147,806 | $17.90 | $2.65M | 162,749 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-02-26 | 2021-03-02 | 299,196 | — | $0 | 310,555 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-24 | 164,496 | — | $0 | 164,496 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-24 | 263,184 | — | $0 | 263,184 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | G Gift | 2020-12-31 | 2021-01-06 | 456,048 | — | $0 | 456,048 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | G Gift | 2020-12-31 | 2021-01-06 | 456,048 | — | $0 | 5 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-17 | 2020-11-17 | 42,708 | — | $0 | 101,409 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-11-17 | 2020-11-17 | 42,708 | $10.03 | $428.4K | 456,053 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-17 | 2020-11-17 | 42,708 | — | $0 | 498,761 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-16 | 2020-11-17 | 22,800 | — | $0 | 144,117 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-11-16 | 2020-11-17 | 22,800 | $10.02 | $228.5K | 456,053 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-16 | 2020-11-17 | 22,800 | — | $0 | 478,853 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-13 | 2020-11-17 | 39,060 | — | $0 | 166,917 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-13 | 2020-11-17 | 3,924 | — | $0 | 10 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-11-13 | 2020-11-17 | 42,984 | $10.01 | $430.3K | 456,053 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-13 | 2020-11-17 | 3,924 | — | $0 | 499,037 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-13 | 2020-11-17 | 39,060 | — | $0 | 495,113 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-12 | 2020-11-12 | 13,917 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-12 | 2020-11-12 | 22,800 | — | $0 | 3,934 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-12 | 2020-11-12 | 27,591 | — | $0 | 205,977 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-12 | 2020-11-12 | 27,591 | — | $0 | 520,361 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-12 | 2020-11-12 | 22,800 | — | $0 | 478,853 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-11-12 | 2020-11-12 | 64,308 | $10.01 | $643.7K | 456,053 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-12 | 2020-11-12 | 13,917 | — | $0 | 492,770 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-09 | 2020-11-12 | 3,600 | — | $0 | 13,917 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-11-09 | 2020-11-12 | 3,600 | — | $0 | 26,734 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-09 | 2020-11-12 | 3,600 | — | $0 | 459,653 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-11-09 | 2020-11-12 | 3,600 | — | $0 | 463,253 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-11-09 | 2020-11-12 | 7,200 | $10.00 | $72.0K | 456,053 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-06-15 | 2020-06-17 | 4,164 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-06-15 | 2020-06-17 | 4,164 | — | $0 | 458,129 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2020-06-15 | 2020-06-17 | 2,076 | $10.23 | $21.2K | 456,053 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-06-04 | 2020-06-08 | 287,904 | — | $0 | 287,904 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-06-04 | 2020-06-08 | 480 | — | $0 | 480 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-03-02 | 2020-03-04 | 17,510 | — | $0 | 7 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-03-02 | 2020-03-04 | 30,334 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-03-02 | 2020-03-04 | 17,510 | — | $0 | 599,369 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-03-02 | 2020-03-04 | 24,456 | $8.31 | $203.2K | 574,913 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-03-02 | 2020-03-04 | 30,334 | — | $0 | 581,859 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-03-02 | 2020-03-04 | 8,400 | $8.40 | $70.6K | 566,513 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-26 | 2020-02-28 | 9,480 | $9.01 | $85.4K | 554,045 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-26 | 2020-02-28 | 1,644 | $9.17 | $15.1K | 552,401 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-26 | 2020-02-28 | 876 | $9.21 | $8.1K | 551,525 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2020-02-03 | 2020-02-05 | 202,224 | — | $0 | 7 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-03 | 2020-02-05 | 110,964 | $9.63 | $1.07M | 583,073 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-03 | 2020-02-05 | 71,712 | $9.57 | $686.3K | 694,037 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-02-03 | 2020-02-05 | 19,548 | $9.71 | $189.8K | 563,525 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2020-02-03 | 2020-02-05 | 202,224 | — | $0 | 765,749 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-12-17 | 2019-12-19 | 10,668 | — | $0 | 11 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-12-17 | 2019-12-19 | 10,668 | — | $0 | 568,865 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-12-17 | 2019-12-19 | 5,340 | $9.17 | $49.0K | 563,525 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-06-14 | 2019-06-18 | 30,936 | — | $0 | 30,936 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-06-14 | 2019-06-18 | 55,488 | — | $0 | 55,488 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award | 2019-06-14 | 2019-06-18 | 16,656 | — | $0 | 558,197 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-05-28 | 2019-05-30 | 202,224 | — | $0 | 202,231 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-28 | 2019-05-30 | 19,284 | $15.43 | $297.6K | 547,553 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-28 | 2019-05-30 | 40,728 | $15.35 | $625.2K | 566,837 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-28 | 2019-05-30 | 26,784 | $15.17 | $406.3K | 664,301 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-28 | 2019-05-30 | 56,736 | $15.25 | $865.2K | 607,565 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-28 | 2019-05-30 | 6,012 | $15.49 | $93.1K | 541,541 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-05-28 | 2019-05-30 | 52,680 | $15.08 | $794.4K | 691,085 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-05-28 | 2019-05-30 | 202,224 | — | $0 | 743,765 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-03-15 | 2019-03-19 | 17,517 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-03-15 | 2019-03-19 | 30,334 | — | $0 | 60,668 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-03-15 | 2019-03-19 | 23,400 | $14.01 | $327.8K | 541,541 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-03-15 | 2019-03-19 | 47,851 | — | $0 | 564,960 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2019-03-15 | 2019-03-19 | 19 | $13.88 | $264 | 564,941 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 17,004 | — | $0 | 17,004 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 17,004 | — | $0 | 17,004 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 17,004 | — | $0 | 17,004 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 17,004 | — | $0 | 17,004 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 226,752 | — | $0 | 226,752 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 119,472 | — | $0 | 119,472 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-02-26 | 2019-02-28 | 22,440 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 96 | $12.28 | $1.2K | 381,773 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-26 | 2019-02-28 | 11,016 | $12.45 | $137.1K | 381,869 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-02-26 | 2019-02-28 | 22,440 | — | $0 | 392,885 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-02-13 | 2019-02-15 | 22,620 | $12.50 | $282.8K | 370,445 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-01-02 | 2019-01-04 | 3,600 | $8.14 | $29.3K | 409,685 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-01-02 | 2019-01-04 | 2,400 | $7.96 | $19.1K | 413,285 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-01-02 | 2019-01-04 | 1,200 | $8.25 | $9.9K | 408,485 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-01-02 | 2019-01-04 | 14,220 | $8.43 | $119.9K | 394,265 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-01-02 | 2019-01-04 | 1,200 | $8.52 | $10.2K | 393,065 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2018-12-20 | 2018-12-26 | 45,240 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2018-12-20 | 2018-12-26 | 45,240 | — | $0 | 415,685 | SEC↗ |